Glucoregulatory Relevance of Small Intestinal Nutrient Sensing in Physiology, Bariatric Surgery, and Pharmacology.

[1]  Yaping Liu,et al.  Selective sodium-dependent glucose transporter 1 inhibitors block glucose absorption and impair glucose-dependent insulinotropic peptide release. , 2015, American journal of physiology. Gastrointestinal and liver physiology.

[2]  R. DePinho,et al.  FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization , 2015, Nature Communications.

[3]  M. Birnbaum,et al.  Hepatic Insulin Signaling is Dispensable for Suppression of Glucose Output by Insulin in Vivo , 2015, Nature Communications.

[4]  D. Philpott,et al.  Regulation of obesity-related insulin resistance with gut anti-inflammatory agents. , 2015, Cell metabolism.

[5]  G. Rutter,et al.  Metformin activates a duodenal Ampk–dependent pathway to lower hepatic glucose production in rats , 2015, Nature Medicine.

[6]  J. Baur,et al.  Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network , 2015, Nature Medicine.

[7]  R. Seeley,et al.  The role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetes. , 2015, Cell metabolism.

[8]  A. Pucci,et al.  Roux-en-Y gastric bypass: effects on feeding behavior and underlying mechanisms. , 2015, The Journal of clinical investigation.

[9]  F. Reimann,et al.  Gut chemosensing mechanisms. , 2015, The Journal of clinical investigation.

[10]  J. Holst,et al.  Improvements in glucose metabolism early after gastric bypass surgery are not explained by increases in total bile acids and fibroblast growth factor 19 concentrations. , 2015, The Journal of clinical endocrinology and metabolism.

[11]  D. Brenner,et al.  Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance , 2015, Nature Medicine.

[12]  Jay H. Chung,et al.  Metabolic effects of resveratrol: addressing the controversies , 2014, Cellular and Molecular Life Sciences.

[13]  B. Viollet,et al.  Metformin: from mechanisms of action to therapies. , 2014, Cell metabolism.

[14]  R. Veit,et al.  Central Insulin Administration Improves Whole-Body Insulin Sensitivity via Hypothalamus and Parasympathetic Outputs in Men , 2014, Diabetes.

[15]  F. Duca,et al.  Fatty acid sensing in the gut and the hypothalamus: In vivo and in vitro perspectives , 2014, Molecular and Cellular Endocrinology.

[16]  G. Lewis,et al.  Intranasal Insulin Suppresses Endogenous Glucose Production in Humans Compared With Placebo in the Presence of Similar Venous Insulin Concentrations , 2014, Diabetes.

[17]  R. Seeley,et al.  Vertical Sleeve Gastrectomy Restores Glucose Homeostasis in Apolipoprotein A-IV KO Mice , 2014, Diabetes.

[18]  Huan Zhao,et al.  Mercaptoacetate and fatty acids exert direct and antagonistic effects on nodose neurons via GPR40 fatty acid receptors. , 2014, American journal of physiology. Regulatory, integrative and comparative physiology.

[19]  G. Dohm,et al.  Effects of Meal Size on the Release of GLP-1 and PYY After Roux-en-Y Gastric Bypass Surgery in Obese Subjects With or Without Type 2 Diabetes , 2014, Obesity Surgery.

[20]  H. Raybould,et al.  Deletion of leptin signaling in vagal afferent neurons results in hyperphagia and obesity , 2014, Molecular metabolism.

[21]  Michael J. MacDonald,et al.  Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase , 2014, Nature.

[22]  Qingbo Su,et al.  Duodenal–Jejunal Bypass Improves Glucose Homeostasis in Association with Decreased Proinflammatory Response and Activation of JNK in the Liver and Adipose Tissue in a T2DM Rat Model , 2014, Obesity Surgery.

[23]  D. Drucker,et al.  Effects of Roux-en-Y gastric bypass on energy and glucose homeostasis are preserved in two mouse models of functional glucagon-like peptide-1 deficiency. , 2014, Molecular metabolism.

[24]  V. Tremaroli,et al.  FXR is a molecular target for the effects of vertical sleeve gastrectomy , 2014, Nature.

[25]  Simon C. Cork,et al.  Identification and Characterization of GLP-1 Receptor–Expressing Cells Using a New Transgenic Mouse Model , 2014, Diabetes.

[26]  F. Duca,et al.  Hormonal Signaling in the Gut* , 2014, The Journal of Biological Chemistry.

[27]  F. Rubino,et al.  Duodenal-Jejunal Bypass and Jejunectomy Improve Insulin Sensitivity in Goto-Kakizaki Diabetic Rats Without Changes in Incretins or Insulin Secretion , 2014, Diabetes.

[28]  J. Holst,et al.  Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery. , 2014, The lancet. Diabetes & endocrinology.

[29]  M. Unno,et al.  Effects of duodeno-jejunal bypass on glucose metabolism in obese rats with type 2 diabetes , 2014, Surgery Today.

[30]  C. Cobelli,et al.  Contribution of Endogenous Glucagon-Like Peptide 1 to Glucose Metabolism After Roux-en-Y Gastric Bypass , 2014, Diabetes.

[31]  R. Seeley,et al.  GLP-1R Responsiveness Predicts Individual Gastric Bypass Efficacy on Glucose Tolerance in Rats , 2014, Diabetes.

[32]  J. Holst,et al.  Effects of Sitagliptin and Metformin Treatment on Incretin Hormone and Insulin Secretory Responses to Oral and “Isoglycemic” Intravenous Glucose , 2014, Diabetes.

[33]  F. Duca,et al.  Jejunal leptin-PI3K signaling lowers glucose production. , 2014, Cell metabolism.

[34]  M. Myers,et al.  Leptin Acts Independently of Food Intake to Modulate Gut Microbial Composition in Male Mice , 2014, Endocrinology.

[35]  G. Dockray.  Enteroendocrine cell signalling via the vagus nerve. , 2013, Current opinion in pharmacology.

[36]  F. Rubino.  From Bariatric to Metabolic Surgery: Definition of a New Discipline and Implications for Clinical Practice , 2013, Current Atherosclerosis Reports.

[37]  Randy J. Seeley,et al.  Cooperation between brain and islet in glucose homeostasis and diabetes , 2013, Nature.

[38]  R. Bergman,et al.  FGF19 action in the brain induces insulin-independent glucose lowering. , 2013, The Journal of clinical investigation.

[39]  M. Carey,et al.  Evidence for Central Regulation of Glucose Metabolism* , 2013, The Journal of Biological Chemistry.

[40]  R. Seeley,et al.  Duodenal nutrient exclusion improves metabolic syndrome and stimulates villus hyperplasia , 2013, Gut.

[41]  J. Ferreira,et al.  A Gut Lipid Messenger Links Excess Dietary Fat to Dopamine Deficiency , 2013, Science.

[42]  R. Batterham,et al.  Peripheral activation of the Y2-receptor promotes secretion of GLP-1 and improves glucose tolerance. , 2013, Molecular metabolism.

[43]  A. Miras,et al.  Mechanisms underlying weight loss after bariatric surgery , 2013, Nature Reviews Gastroenterology &Hepatology.

[44]  Myung-Shik Lee,et al.  An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice , 2013, Gut.

[45]  J. Holst,et al.  The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty. , 2013, American Journal of Physiology - Gastrointestinal and Liver Physiology.

[46]  R. Seeley,et al.  Vertical Sleeve Gastrectomy Is Effective in Two Genetic Mouse Models of Glucagon-Like Peptide 1 Receptor Deficiency , 2013, Diabetes.

[47]  W. Strodel,et al.  A Role for Fibroblast Growth Factor 19 and Bile Acids in Diabetes Remission After Roux-en-Y Gastric Bypass , 2013, Diabetes Care.

[48]  Avis J. Thomas,et al.  Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. , 2013, JAMA.

[49]  D. Drucker,et al.  Pharmacology, physiology, and mechanisms of incretin hormone action. , 2013, Cell metabolism.

[50]  J. Holst,et al.  Characterisation of oral and i.v. glucose handling in truncally vagotomised subjects with pyloroplasty , 2013, European journal of endocrinology.

[51]  Sanyuan Hu,et al.  Duodenal–Jejunal Bypass Improves Glucose Metabolism and Adipokine Expression Independently of Weight Loss in a Diabetic Rat Model , 2013, Obesity Surgery.

[52]  F. Nassir,et al.  CD36‐dependent signaling mediates fatty acid‐induced gut release of secretin and cholecystokinin , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[53]  S. Klein,et al.  Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids. , 2013, The Journal of clinical endocrinology and metabolism.

[54]  J. Holst,et al.  Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass , 2013, International Journal of Obesity.

[55]  J. Olefsky,et al.  Restoration of Euglycemia After Duodenal Bypass Surgery Is Reliant on Central and Peripheral Inputs in Zucker fa/fa Rats , 2013, Diabetes.

[56]  A. Lacy,et al.  GLP-1 Action and Glucose Tolerance in Subjects With Remission of Type 2 Diabetes After Gastric Bypass Surgery , 2013, Diabetes Care.

[57]  H. Berthoud,et al.  Roux‐en‐Y gastric bypass surgery increases number but not density of CCK‐, GLP‐1‐, 5‐HT‐, and neurotensin‐expressing enteroendocrine cells in rats , 2013, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[58]  B. Viollet,et al.  Biguanides suppress hepatic glucagon signaling by decreasing production of cyclic AMP , 2016 .

[59]  G. Schwartz,et al.  Duodenal Lipid Sensing Activates Vagal Afferents to Regulate Non-Shivering Brown Fat Thermogenesis in Rats , 2012, PloS one.

[60]  Sanyuan Hu,et al.  The Entire Small Intestine Mediates the Changes in Glucose Homeostasis After Intestinal Surgery in Goto-Kakizaki Rats , 2012, Annals of surgery.

[61]  Kozo Matsumoto,et al.  Genetic Dissection of Complex Genetic Factor Involved in NIDDM of OLETF Rat , 2012, Experimental diabetes research.

[62]  E. Zoetendal,et al.  Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. , 2012, Gastroenterology.

[63]  F. Rubino,et al.  Diabetes remission without weight loss after duodenal bypass surgery. , 2012, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[64]  E. Cuppen,et al.  Effect of vertical sleeve gastrectomy in melanocortin receptor 4-deficient rats. , 2012, American journal of physiology. Endocrinology and metabolism.

[65]  D. Cummings,et al.  Effects of Gastric Bypass Surgery in Patients With Type 2 Diabetes and Only Mild Obesity , 2012, Diabetes Care.

[66]  P. Richards,et al.  Predominant role of active versus facilitative glucose transport for glucagon-like peptide-1 secretion , 2012, Diabetologia.

[67]  Rennian Wang,et al.  Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes , 2012, Nature Medicine.

[68]  D. Edgerton,et al.  Evidence against a physiologic role for acute changes in CNS insulin action in the rapid regulation of hepatic glucose production. , 2012, Cell metabolism.

[69]  R. de Cabo,et al.  SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. , 2012, Cell metabolism.

[70]  F. Rubino,et al.  Bariatric surgery versus conventional medical therapy for type 2 diabetes. , 2012, The New England journal of medicine.

[71]  Deepak L. Bhatt,et al.  Bariatric surgery versus intensive medical therapy in obese patients with diabetes. , 2012, The New England journal of medicine.

[72]  R. Ritter,et al.  CCK-induced reduction of food intake and hindbrain MAPK signaling are mediated by NMDA receptor activation. , 2012, Endocrinology.

[73]  S. Kahn,et al.  Colesevelam Improves Oral but Not Intravenous Glucose Tolerance by a Mechanism Independent of Insulin Sensitivity and β-Cell Function , 2012, Diabetes Care.

[74]  T. Lam,et al.  Duodenal activation of cAMP-dependent protein kinase induces vagal afferent firing and lowers glucose production in rats. , 2012, Gastroenterology.

[75]  G. Dohm,et al.  GLP-1 Response to a Mixed Meal: What Happens 10 Years after Roux-en-Y Gastric Bypass (RYGB)? , 2012, Obesity Surgery.

[76]  Shaozhuang Liu,et al.  A high-fat diet reverses improvement in glucose tolerance induced by duodenal-jejunal bypass in type 2 diabetic rats. , 2012, Chinese medical journal.

[77]  H. Ke,et al.  Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases , 2012, Cell.

[78]  Li Yang,et al.  Chylomicron Formation and Secretion is Required for Lipid-Stimulated Release of Incretins GLP-1 and GIP , 2012, Lipids.

[79]  H. Parker,et al.  Na+-d-glucose Cotransporter SGLT1 is Pivotal for Intestinal Glucose Absorption and Glucose-Dependent Incretin Secretion , 2011, Diabetes.

[80]  G. Schwartz,et al.  Activation of K(ATP) channels suppresses glucose production in humans. , 2011, The Journal of clinical investigation.

[81]  R. Ritter.  A tale of two endings: Modulation of satiation by NMDA receptors on or near central and peripheral vagal afferent terminals , 2011, Physiology & Behavior.

[82]  J. Yue,et al.  Duodenal PKC-δ and Cholecystokinin Signaling Axis Regulates Glucose Production , 2011, Diabetes.

[83]  J. Auwerx,et al.  Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. , 2011, Cell metabolism.

[84]  T. Lam,et al.  Duodenal mucosal protein kinase C-δ regulates glucose production in rats. , 2011, Gastroenterology.

[85]  H. Grill,et al.  The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1. , 2011, American journal of physiology. Regulatory, integrative and comparative physiology.

[86]  P. Brubaker,et al.  Mechanisms underlying metformin-induced secretion of glucagon-like peptide-1 from the intestinal L cell. , 2011, Endocrinology.

[87]  G. Schwartz.  Gut fat sensing in the negative feedback control of energy balance — Recent advances , 2011, Physiology & Behavior.

[88]  S. Woods,et al.  Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats. , 2011, Gastroenterology.

[89]  D. D’Alessio,et al.  Gastric Bypass Surgery Enhances Glucagon-Like Peptide 1–Stimulated Postprandial Insulin Secretion in Humans , 2011, Diabetes.

[90]  R. Ritter,et al.  Reduction of food intake by cholecystokinin requires activation of hindbrain NMDA-type glutamate receptors. , 2011, American journal of physiology. Regulatory, integrative and comparative physiology.

[91]  T. Yada,et al.  AMP-activated protein kinase activates neuropeptide Y neurons in the hypothalamic arcuate nucleus to increase food intake in rats , 2011, Neuroscience Letters.

[92]  J. Holst,et al.  Physiological and pharmacological mechanisms through which the DPP-4 inhibitor sitagliptin regulates glycemia in mice. , 2011, Endocrinology.

[93]  D. Drucker,et al.  Resveratrol Increases Glucose Induced GLP-1 Secretion in Mice: A Mechanism which Contributes to the Glycemic Control , 2011, PloS one.

[94]  F. Rubino,et al.  Duodenal-jejunal bypass protects GK rats from {beta}-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1. , 2011, American journal of physiology. Endocrinology and metabolism.

[95]  W. Scott,et al.  Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery. , 2011, American journal of physiology. Regulatory, integrative and comparative physiology.

[96]  Megan E. Drew,et al.  Diet and Gastrointestinal Bypass–Induced Weight Loss , 2011, Diabetes.

[97]  D. Drucker,et al.  Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice , 2011, Diabetologia.

[98]  S. Pechhold,et al.  The extracellular calcium-sensing receptor is required for cholecystokinin secretion in response to L-phenylalanine in acutely isolated intestinal I cells. , 2011, American journal of physiology. Gastrointestinal and liver physiology.

[99]  H. Kwon,et al.  Early Changes in Incretin Secretion After Laparoscopic Duodenal–Jejunal Bypass Surgery in Type 2 Diabetic Patients , 2010, Obesity surgery.

[100]  G. Rutter,et al.  Hypothalamic AMP-Activated Protein Kinase Regulates Glucose Production , 2010, Diabetes.

[101]  G. Lur,et al.  EGR1 Is a target for cooperative interactions between cholecystokinin and leptin, and inhibition by ghrelin, in vagal afferent neurons. , 2010, Endocrinology.

[102]  M. R. Hayes,et al.  Role of the glucagon-like-peptide-1 receptor in the control of energy balance , 2010, Physiology & Behavior.

[103]  B. Viollet,et al.  Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. , 2010, The Journal of clinical investigation.

[104]  Vasilis G. Moisiadis,et al.  OPG and RANK Polymorphisms Are Both Associated with Cortical Bone Mineral Density: Findings from a Metaanalysis of the Avon Longitudinal Study of Parents and Children and Gothenburg Osteoporosis and Obesity Determinants Cohorts , 2010, Journal of Clinical Endocrinology and Metabolism.

[105]  S. Woods,et al.  Sleeve gastrectomy induces loss of weight and fat mass in obese rats, but does not affect leptin sensitivity. , 2010, Gastroenterology.

[106]  A. Rotondo,et al.  Peripheral motor action of glucagon‐like peptide‐1 through enteric neuronal receptors , 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[107]  L. Miller,et al.  Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor , 2010, British journal of pharmacology.

[108]  S. Skeie,et al.  Six Months of Diazoxide Treatment at Bedtime in Newly Diagnosed Subjects With Type 1 Diabetes Does Not Influence Parameters of β-Cell Function and Autoimmunity but Improves Glycemic Control , 2009, Diabetes Care.

[109]  T. Seo,et al.  Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice. , 2009, American journal of physiology. Endocrinology and metabolism.

[110]  J. Holst,et al.  Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid Metabolism , 2009, Obesity.

[111]  T. Lam,et al.  Intestinal cholecystokinin controls glucose production through a neuronal network. , 2009, Cell metabolism.

[112]  C. Beglinger,et al.  Improvement in Glucose Metabolism After Bariatric Surgery: Comparison of Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Sleeve Gastrectomy: A Prospective Randomized Trial , 2009, Annals of surgery.

[113]  D. Andersen,et al.  Clinical review: The extrapancreatic effects of glucagon-like peptide-1 and related peptides. , 2009, The Journal of clinical endocrinology and metabolism.

[114]  D. Cummings,et al.  Minireview: Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. , 2009, Endocrinology.

[115]  R. Seeley,et al.  Duodenal-Jejunal Exclusion Improves Glucose Tolerance in the Diabetic, Goto-Kakizaki Rat by a GLP-1 Receptor-Mediated Mechanism , 2009, Journal of Gastrointestinal Surgery.

[116]  P. Puigserver,et al.  AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity , 2009, Nature.

[117]  D. Cummings,et al.  Normal feeding and body weight in Fischer 344 rats lacking the cholecystokinin-1 receptor gene , 2009, Brain Research.

[118]  M. Crowell,et al.  Human gut microbiota in obesity and after gastric bypass , 2009, Proceedings of the National Academy of Sciences.

[119]  A. M. Habib,et al.  Glucose Sensing in L Cells: A Primary Cell Study , 2008, Cell metabolism.

[120]  D. D’Alessio,et al.  Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion. , 2008, The Journal of clinical endocrinology and metabolism.

[121]  J. Auwerx,et al.  Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. , 2008, Cell metabolism.

[122]  N. Ruderman,et al.  SIRT1 Modulation of the Acetylation Status, Cytosolic Localization, and Activity of LKB1 , 2008, Journal of Biological Chemistry.

[123]  S. Gaetani,et al.  The lipid messenger OEA links dietary fat intake to satiety. , 2008, Cell metabolism.

[124]  R. Rogers,et al.  Mechanisms of action of CCK to activate central vagal afferent terminals , 2008, Peptides.

[125]  B. Viollet,et al.  Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. , 2008, Cell metabolism.

[126]  H. Edlund,et al.  Gpr40 Is Expressed in Enteroendocrine Cells and Mediates Free Fatty Acid Stimulation of Incretin Secretion , 2008, Diabetes.

[127]  Fan Lan,et al.  SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein Kinase* , 2008, Journal of Biological Chemistry.

[128]  J. Holst,et al.  Glucagon-like peptide receptor agonists and dipeptidyl peptidase-4 inhibitors in the treatment of diabetes: a review of clinical trials , 2008, Current opinion in clinical nutrition and metabolic care.

[129]  E. Hoffman,et al.  Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. , 2008, Developmental cell.

[130]  P. Light,et al.  Upper intestinal lipids trigger a gut–brain–liver axis to regulate glucose production , 2008, Nature.

[131]  A. Kalsbeek,et al.  Daily rhythms in metabolic liver enzymes and plasma glucose require a balance in the autonomic output to the liver. , 2008, Endocrinology.

[132]  A. Lacy,et al.  Circulating Peptide YY, Weight Loss, and Glucose Homeostasis After Gastric Bypass Surgery in Morbidly Obese Subjects , 2008, Annals of surgery.

[133]  M. Suter,et al.  Effects of Gastric Bypass and Gastric Banding on Glucose Kinetics and Gut Hormone Release , 2008, Obesity.

[134]  S. Bloom,et al.  Gut Hormones as Mediators of Appetite and Weight Loss After Roux-en-Y Gastric Bypass , 2007, Annals of surgery.

[135]  J. Holst.  The physiology of glucagon-like peptide 1. , 2007, Physiological reviews.

[136]  S. Woods,et al.  Interaction of apolipoprotein AIV with cholecystokinin on the control of food intake. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[137]  S. Woods,et al.  Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats. , 2007, Endocrinology.

[138]  T. Lam,et al.  A balance of lipid-sensing mechanisms in the brain and liver. , 2007, Cell metabolism.

[139]  Jing Chen,et al.  Differential body weight and feeding responses to high-fat diets in rats and mice lacking cholecystokinin 1 receptors. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[140]  M Sullivan,et al.  Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study , 2007, International Journal of Obesity.

[141]  F. Rubino,et al.  Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases. , 2007, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[142]  D. Cummings,et al.  Gastrointestinal regulation of food intake. , 2007, The Journal of clinical investigation.

[143]  P. Puigserver,et al.  Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α , 2006, Cell.

[144]  M. Schwartz,et al.  Leptin Regulation of the Anorexic Response to Glucagon-Like Peptide-1 Receptor Stimulation , 2006, Diabetes.

[145]  P. Puigserver,et al.  Resveratrol improves health and survival of mice on a high-calorie diet , 2006, Nature.

[146]  J. Marescaux,et al.  The Mechanism of Diabetes Control After Gastrointestinal Bypass Surgery Reveals a Role of the Proximal Small Intestine in the Pathophysiology of Type 2 Diabetes , 2006, Annals of surgery.

[147]  L. Rossetti,et al.  Molecular disruption of hypothalamic nutrient sensing induces obesity , 2006, Nature Neuroscience.

[148]  R. Batterham,et al.  Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters , 2006, Annals of surgery.

[149]  P. Tso,et al.  Apolipoprotein A‐IV is involved in detection of lipid in the rat intestine , 2005, The Journal of physiology.

[150]  K. Toshinai,et al.  The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. , 2005, Endocrinology.

[151]  D. Drucker,et al.  Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure. , 2004, Gastroenterology.

[152]  T. Kigoshi,et al.  Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells , 2004, Autonomic Neuroscience.

[153]  J. Marescaux,et al.  Effect of Duodenal–Jejunal Exclusion in a Non-obese Animal Model of Type 2 Diabetes: A New Perspective for an Old Disease , 2004, Annals of surgery.

[154]  L. Kuller,et al.  Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes Mellitus , 2003 .

[155]  A. Bado,et al.  Duodenal leptin stimulates cholecystokinin secretion: evidence of a positive leptin-cholecystokinin feedback loop. , 2003, Diabetes.

[156]  N. Bellissimo,et al.  Cholecystokinin-A receptors are involved in food intake suppression in rats after intake of all fats and carbohydrates tested. , 2003, The Journal of nutrition.

[157]  Roberto Conti,et al.  Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production , 2003, Nature Medicine.

[158]  A. Hoffman,et al.  Pharmacokinetic-pharmacodynamic analysis of the glucose-lowering effect of metformin in diabetic rats reveals first-pass pharmacodynamic effect. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[159]  D. Thompson,et al.  Expression of the leptin receptor in rat and human nodose ganglion neurones , 2002, Neuroscience.

[160]  D. Drucker,et al.  Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor. , 2001, Diabetes.

[161]  C. Beglinger,et al.  Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[162]  S. Brookes,et al.  Anatomy and physiology of the enteric nervous system , 2000, Gut.

[163]  K. Mitamura,et al.  Involvement of Calmodulin and Protein Kinase C in Cholecystokinin Release by Bombesin from STC-1 Cells , 2000, Pancreas.

[164]  C. Chang,et al.  Cellular mechanism of sodium oleate-stimulated secretion of cholecystokinin and secretin. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[165]  M. Owen,et al.  Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. , 2000, The Biochemical journal.

[166]  L. Lissner,et al.  Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. , 1999, Obesity research.

[167]  A. Bado,et al.  The stomach is a source of leptin , 1998, Nature.

[168]  P. Tso,et al.  Inhibition of gastric emptying in response to intestinal lipid is dependent on chylomicron formation. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[169]  Y. Taché,et al.  Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[170]  V. Mazzaferro,et al.  Regulation of glucose homeostasis in humans with denervated livers. , 1997, The Journal of clinical investigation.

[171]  Jie Ren,et al.  First Intracellular Loop of the Human Cholecystokinin-A Receptor Is Essential for Cyclic AMP Signaling in Transfected HEK-293 Cells* , 1997, The Journal of Biological Chemistry.

[172]  A. Wittgrove,et al.  Laparoscopic Gastric Bypass, Roux en-Y: Technique and Results in 75 Patients With 3-30 Months Follow-up , 1996, Obesity surgery.

[173]  A. Joyner,et al.  Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene , 1996, Nature Medicine.

[174]  A. Niijima,et al.  Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1. , 1996, The American journal of physiology.

[175]  J. Romijn,et al.  Truncal vagotomy does not affect postabsorptive glucose metabolism in humans. , 1995, Journal of applied physiology.

[176]  H. Berthoud,et al.  Vagal sensors in the rat duodenal mucosa: distribution and structure as revealed by in vivo DiI-tracing , 1995, Anatomy and Embryology.

[177]  B. Göke,et al.  Reduction of the Incretin Effect in Rats by the Glucagon-Like Peptide 1 Receptor Antagonist Exendin (9–39) Amide , 1995, Diabetes.

[178]  K. Kawano,et al.  Spontaneous Long-Term Hyperglycemic Rat With Diabetic Complications: Otsuka Long-Evans Tokushima Fatty (OLETF) Strain , 1992, Diabetes.

[179]  H. Raybould,et al.  Dual capsaicin-sensitive afferent pathways mediate inhibition of gastric emptying in rat induced by intestinal carbohydrate , 1992, Neuroscience Letters.

[180]  J. Williams,et al.  Multiple sources of 1,2-diacylglycerol in isolated rat pancreatic acini stimulated by cholecystokinin. Involvement of phosphatidylinositol bisphosphate and phosphatidylcholine hydrolysis. , 1989, The Journal of biological chemistry.

[181]  P. Cryer,et al.  Direct muscarinic cholinergic inhibition of hepatic glucose production in humans. , 1988, The Journal of clinical investigation.

[182]  H. Raybould,et al.  Mechanisms of action of peripherally administered cholecystokinin octapeptide on brain stem neurons in the rat , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[183]  D. Johnston,et al.  Effects of truncal, selective, and highly selective vagotomy on glucose tolerance and insulin secretion in patients with duodenal ulcer. Part II-Comparison of response to oral and intravenous glucose. , 1975, British medical journal.

[184]  C. Streutker,et al.  GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-/-) mice. , 2013, Endocrinology.

[185]  R. Seeley,et al.  The effects of vertical sleeve gastrectomy in rodents are ghrelin independent. , 2013, Gastroenterology.

[186]  E. Ferrannini,et al.  Direct effect of GLP-1 infusion on endogenous glucose production in humans , 2012, Diabetologia.

[187]  G. Tsujimoto,et al.  Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120 , 2005, Nature Medicine.

[188]  A. Pocai,et al.  A brain-liver circuit regulates glucose homeostasis. , 2005, Cell metabolism.

[189]  H. Berthoud,et al.  Vagal afferents innervating the gastrointestinal tract and CCKA‐receptor immunoreactivity , 2002, The Anatomical record.

[190]  S. Bloom,et al.  Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. , 1999, Diabetes.

[191]  D. Smith,et al.  Glucagon-like peptide-1 is a physiological incretin in rat. , 1995, The Journal of clinical investigation.